493 results on '"Ståhle, Mona"'
Search Results
2. A long-term, prospective, observational cohort study of the safety and effectiveness of etanercept for the treatment of patients with paediatric psoriasis in a naturalistic setting
3. A gene-centric approach to biomarker discovery identifies transglutaminase 1 as an epidermal autoantigen
4. A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17
5. Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study
6. Microscopic Colitis and Risk of Incident Psoriasis: A Nationwide Population-Based Matched Cohort Study
7. miR-19a/b and miR-20a Promote Wound Healing by Regulating the Inflammatory Response of Keratinocytes
8. MicroRNA-34 Family Enhances Wound Inflammation by Targeting LGR4
9. Bimekizumab Efficacy in Patients with Moderate to Severe Plaque Psoriasis and Hypertension, Elevated Body Mass Index, or Hyperglycemia: Results Through 3 years of Treatment in 5 Phase 3/3b Trials
10. Human skin long noncoding RNA WAKMAR1 regulates wound healing by enhancing keratinocyte migration
11. WAKMAR2, a Long Noncoding RNA Downregulated in Human Chronic Wounds, Modulates Keratinocyte Motility and Production of Inflammatory Chemokines
12. Interleukin-17 and - 23 Inhibitors Associated with Direct Effects on Depressive Symptoms in Psoriasis: Results from a Register Study
13. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis
14. The prevalence of ADH1B and OPRM1 alleles predisposing for alcohol consumption are increased in the Hungarian psoriasis population
15. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
16. HypoxamiR-210 accelerates wound healing in diabetic mice by improving cellular metabolism
17. MicroRNA-132 with Therapeutic Potential in Chronic Wounds
18. Rare coding variants inNOX4link high superoxide levels to psoriatic arthritis mutilans
19. Dynamic Changes in Resident and Infiltrating Epidermal Dendritic Cells in Active and Resolved Psoriasis
20. MicroRNA-146a suppresses IL-17–mediated skin inflammation and is genetically associated with psoriasis
21. Type 1 and type 2 psoriasis revisited: No association between age at onset and disease course
22. Wound Repair and Antimicrobial Peptides
23. Itch Is More Important than Clinical Disease Severity for Depression in Psoriasis: A Prospective Register Study
24. European consensus statement on phenotypes of pustular psoriasis
25. Identification of chronological and photoageing-associated microRNAs in human skin
26. Transition from inflammation to proliferation: a critical step during wound healing
27. Granzyme A potentiates chemokine production in IL‐17‐stimulated keratinocytes
28. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin
29. Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study
30. Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis: Analysis of Results From 3 Randomized Phase 3 Clinical Trials
31. Sebocytes differentially express and secrete adipokines
32. A long-term, prospective, observational cohort study of the safety and effectiveness of etanercept for the treatment of patients with paediatric psoriasis in a naturalistic setting.
33. Risk of respiratory infection in patients with plaque psoriasis
34. SKIN, A DISPLAY ORGAN FOR THE IMMUNE SYSTEM — AN UPDATE ON PUTATIVE THERAPY TARGETS
35. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte–associated antigen 4
36. MicroRNA-132 enhances transition from inflammation to proliferation during wound healing
37. Psoriasis: in between the skin and the fat
38. HLA-B[*]27 is significantly enriched in Nordic patients with psoriatic arthritis mutilans
39. Long-term Outcomes and Prognosis in New-Onset Psoriasis
40. Chromatin interactions in differentiating keratinocytes reveal novel atopic dermatitis– and psoriasis-associated genes
41. Chromatin interactions in differentiating keratinocytes reveal novel atopic dermatitis- and psoriasis-associated genes
42. Comorbidities in a Cohort of 66 Patients With Psoriatic Arthritis Mutilans-Results From the Nordic PAM Study
43. Interaction between Smoking and HLA-C*06:02 on the Response to Ustekinumab in Psoriasis
44. Genetic polymorphisms altering microRNA activity in psoriasis – a key to solve the puzzle of missing heritability?
45. Identification of novel non-coding RNA-based negative feedback regulating the expression of the oncogenic transcription factor GLI1
46. Systemic treatment and narrowband ultraviolet B differentially affect cardiovascular risk markers in psoriasis
47. Activation of Toll-like receptors alters the microRNA expression profile of keratinocytes
48. Comorbidities in a Cohort of 66 Patients With Psoriatic Arthritis Mutilans—Results From the Nordic PAM Study
49. Metabolic disorders in patients with psoriasis and psoriatic arthritis
50. Radiographic scoring systems for psoriatic arthritis are insufficient for psoriatic arthritis mutilans : results from the Nordic PAM Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.